Hims & Hers Health, Inc.
For the period ended Jun 30, 2025. Filed Aug 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 4, 2025
HIMS$19.13-16.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In Thousands, Except Share and Per Share Data)
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $1,124,582 | $220,584 |
| Short-term investments | 20,033 | 79,667 |
| Inventory | 141,800 | 64,427 |
| Prepaid expenses and other current assets | 69,151 | 31,153 |
| Total current assets | 1,355,566 | 395,831 |
| Restricted cash | 368 | 856 |
| Goodwill | 117,753 | 112,728 |
| Property, equipment, and software, net | 205,480 | 82,083 |
| Intangible assets, net | 40,657 | 43,410 |
| Operating lease right-of-use assets | 71,661 | 10,881 |
| Deferred tax assets, net | 84,229 | 61,603 |
| Other long-term assets | 1,868 | 147 |
| Total assets | $1,877,582 | $707,539 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $105,009 | $91,180 |
| Accrued liabilities | 65,671 | 53,013 |
| Deferred revenue | 98,417 | 75,285 |
| Operating lease liabilities | 3,135 | 1,889 |
| Total current liabilities | 272,232 | 221,367 |
| Convertible senior notes, net | 969,467 | — |
| Operating lease liabilities | 71,786 | 9,456 |
| Other long-term liabilities | 1,401 | — |
| Total liabilities | 1,314,886 | 230,823 |
| Commitments and contingencies (Note 14) | ||
| Stockholders' equity: | ||
| Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 217,381,434 and 212,459,586 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of June 30, 2025 and December 31, 2024 | 23 | 22 |
| Additional paid-in capital | 711,998 | 719,155 |
| Accumulated other comprehensive income (loss) | 822 | (324) |
| Accumulated deficit | (150,147) | (242,137) |
| Total stockholders' equity | 562,696 | 476,716 |
| Total liabilities and stockholders' equity | $1,877,582 | $707,539 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.